Research Article

Early Right Ventricular Apical Pacing-Induced Gene Expression Alterations Are Associated with Deterioration of Left Ventricular Systolic Function

Table 1

Summary of patient characteristics.

VariablesOverallRVARVOT Value

Age67.9 ± 8.467.1 ± 7.568.7 ± 9.30.477
Male (%)33 (55.0)17 (56.7)16 (53.3)0.795
BMI24.1 ± 2.3723.7 ± 2.524.4 ± 2.20.294
SBP139 ± 21142 ± 22137 ± 200.377
DBP73 ± 1775 ± 1871 ± 160.372
Hypertension (%)28 (46.7)15 (50)13 (43.3)0.605
Diabetes mellitus (%)12 (20.0)5 (16.7)7 (23.3)0.519
Coronary heart disease (%)13 (21.7)6 (20.0)7 (23.3)0.754
ACEI/ARB (%)19 (31.7)8 (26.7)11 (36.7)0.405
Beta-blockers (%)12 (20.0)7 (23.3)5 (16.7)0.519
Statins (%)17 (28.3)8 (26.7)9 (30)0.774
Prepacing QRS duration (ms)103 ± 13102 ± 11105 ± 140.375
Paced QRS duration (ms)143 ± 16154 ± 12132 ± 11<0.001
BNP242.5 (203.3–298.5)235.4 (198.1–289.5)259.3 (210.3–309.0)0.469
LAV (mL)33.9 ± 4.433.4 ± 3.934.3 ± 4.90.435
LVEDV (mL)100.9 ± 11.9103.2 ± 11.498.6 ± 12.20.139
LVESV (mL)38.4 ± 6.137.8 ± 5.139.0 ± 7.00.452
LVEF (%)62.7 ± 5.763.0 ± 5.462.4 ± 6.10.704
EA ratio1.03 ± 0.210.99 ± 0.201.07 ± 0.220.121
GLS (%)−13.0 ± 2.8−13.2 ± 2.4−12.9 ± 3.00.746
GRS (%)29.0 ± 5.729.7 ± 5.728.2 ± 5.20.311
GCS (%)−20.3 ± 5.0−20.8 ± 4.4−19.8 ± 5.50.441
SDI12.2 ± 2.112.1 ± 1.912.3 ± 2.10.852
MWD (m)377.9 ± 39.0381.9 ± 31.1374.9 ± 44.90.562

BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; ACEI: angiotensin-converting enzyme inhibitors; ARB: angiotensin receptor blockers; VP: ventricular pacing; BNP: brain natriuretic peptide; LAV: left atrial volume; LVEDV: left ventricular end-diastolic volume; LVESV: left ventricular end-systolic volume; LVEF: left ventricular ejection fraction; GLS: global longitudinal strain; GRS: global radial strain; GCS: global circumferential strain; SDI: standard deviation index of three-dimensional strain; MWD: 6-min walking distance.